Implementing interventions to start HPV vaccination at age 9: Using the evidence we have

References

• Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1405–8. doi:10.15585/mmwr.mm6549a5. PMID: 27977643.
   PubMed Web of Science ®Google Scholar
• Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698–702. doi:10.15585/mmwr.mm6832a3. PMID: 31415491; PMCID: PMC6818701.
   PubMed Web of Science ®Google Scholar
• Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Centers for disease control and prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300–04. PMID: 25811679; PMCID: PMC4584883.
   PubMed Web of Science ®Google Scholar
• Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, Crowe SJ, Stokley S, Singleton JA. National vaccination coverage among adolescents aged 13-17 years - national immunization survey-teen, United States, 2021. Morb Mortal Wkly Rep. 2022 Sep 2;71(35):1101–08. doi:10.15585/mmwr.mm7135a1. PMID: 36048724; PMCID: PMC9472778.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, United States Department of Health and Human Services. Reasons to Get Vaccinated; 2021 Nov 21 [accessed 2022 Nov 1]. https://www.cdc.gov/hpv/parents/vaccine/six-reasons.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fhpv%2Finfographics%2Fvacc-six-reasons.html.
   Google Scholar
• Arbyn M, Xu L, Simoens C, Martin-Hirsch PP Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. PMID: 29740819; PMCID: PMC6494566.
   Google Scholar
• Falcaro M, Castañon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, Elliss-Brookes L, Sasieni P. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021 Dec 4;398(10316):2084–92. doi:10.1016/S0140-6736(21)02178-4. Epub 2021 Nov 3. PMID: 34741816.
   PubMed Web of Science ®Google Scholar
• Herweijer E, Sundström K, Ploner A, Uhnoo I, Sparén P, Arnheim-Dahlström L. Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: a population-based study. Int J Cancer. 2016 Jun 15;138(12):2867–74. doi:10.1002/ijc.30035. Epub 2016 Mar 9. Erratum in: Int J Cancer. 2017 Jul 1;141(1):E1-E4. PMID: 26856527; PMCID: PMC5069657.
   PubMed Web of Science ®Google Scholar
• Kjaer SK, Dehlendorff C, Belmonte F, Baandrup L. Real-world effectiveness of human papillomavirus vaccination against cervical cancer. J Natl Cancer Inst. 2021 Oct 1;113(10):1329–35. doi:10.1093/jnci/djab080. PMID: 33876216; PMCID: PMC8486335.
   PubMedGoogle Scholar
• Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, et al. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials. BMJ Open. 2017 Aug 18;7(8):e015867. doi:10.1136/bmjopen-2017-015867. PMID: 28821519; PMCID: PMC5629648.
   PubMed Web of Science ®Google Scholar
• Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020 Oct 1;383(14):1340–48. doi:10.1056/NEJMoa1917338. PMID: 32997908.
   PubMed Web of Science ®Google Scholar
• Palmer T, Wallace L, Pollock KG, Cuschieri K, Robertson C, Kavanagh K, Cruickshank M. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study. BMJ. 2019 Apr 3;365:l1161. doi:10.1136/bmj.l1161. PMID: 30944092; PMCID: PMC6446188.
   PubMedGoogle Scholar
• Perkins RB, Lin M, Wallington SF, Hanchate A Impact of number of human papillomavirus vaccine doses on genital warts diagnoses among a national cohort of U.S. adolescents. Sex Transm Dis. 2017 Jun;44(6):365–70. doi:10.1097/OLQ.0000000000000615. PMID: 28499288; PMCID: PMC5502820.
   PubMed Web of Science ®Google Scholar
• National Committee for Quality Assurance. Immunizations for adolescents (IMA); 2021 [accessed 2022 Nov 1]. https://www.ncqa.org/hedis/%20measures/immunizations-for-adolescents/.
   Google Scholar
• Bednarczyk RA, Ellingson MK, Omer SB. Human papillomavirus vaccination before 13 and 15 years of age: analysis of national immunization survey teen data. J Infect Dis. 2019 Jul 31;220(5):730–34. doi:10.1093/infdis/jiy682. PMID: 30657920; PMCID: PMC6667791.
   PubMed Web of Science ®Google Scholar
• Biancarelli DL, Drainoni ML, Perkins RB. Provider experience recommending HPV vaccination before age 11 years. J Pediatr. 2020 Feb;217:92–97. doi:10.1016/j.jpeds.2019.10.025. Epub 2019 Nov 19. PMID: 31757474.
   PubMed Web of Science ®Google Scholar
• Goleman MJ, Dolce M, Morack J Quality improvement initiative to improve human papillomavirus vaccine initiation at 9 years of age. Acad Pediatr. 2018 Sep-Oct;18(7):769–75. doi:10.1016/j.acap.2018.05.005. Epub 2018 May 26. PMID: 29842924.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Legler A, Jansen E, Bernstein J, Pierre-Joseph N, Eun TJ, Biancarelli DL, Schuch TJ, Leschly K, Athr F, et al. Improving HPV vaccination rates: a stepped-wedge randomized trial. Pediatrics. 2020 Jul;146(1):e20192737. doi:10.1542/peds.2019-2737. Epub 2020 Jun 15. PMID: 32540986.
   PubMed Web of Science ®Google Scholar
• National HPV Vaccination Roundtable. Evidence summary: HPV vaccination at 9-12 years of age; 2022 April [accessed 2022 Nov 1]. https://hpvroundtable.org/wp-content/uploads/2022/04/Evidence-Summary-HPV-Vaccination-Age-9-12-Final.pdf.
   Google Scholar
• St Sauver JL, Rutten LJF, Ebbert JO, Jacobson DJ, McGree ME, Jacobson RM. Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion. Prev Med. 2016 Aug;89:327–33. doi:10.1016/j.ypmed.2016.02.039. Epub 2016 Feb 28. PMID: 26930513; PMCID: PMC4969174.
   PubMed Web of Science ®Google Scholar
• Kong WY, Huang Q, Thompson P, Grabert BK, Brewer NT, Gilkey MB Recommending human papillomavirus vaccination at age 9: a national survey of primary care professionals. Acad Pediatr. 2022 May-Jun;22(4):573–80. doi:10.1016/j.acap.2022.01.008. Epub 2022 Jan 23. PMID: 35081470; PMCID: PMC9081141.
   PubMed Web of Science ®Google Scholar
• O’leary ST, Nyquist AC Why AAP recommends initiating HPV vaccination as early as age 9; 2019 Oct 4 [accessed 2022 Nov 1]. https://www.aappublications.org/news/2019/10/04/hpv100419.
   Google Scholar
• Saslow D, Andrews KS, Manassaram-Baptiste D, Smith RA, Fontham ETH, American Cancer Society Guideline Development Group. Human papillomavirus vaccination 2020 guideline update: American cancer society guideline adaptation. CA Cancer J Clin. 2020 Jul;70(4):274–80. doi:10.3322/caac.21616. Epub 2020 Jul 8. PMID: 32639044.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, United States Department of Health and Human Services; 2021 Nov 21 [accessed 2022 Nov 1]. https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html.
   Google Scholar
• Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychol. 2015 Sep 16;3(1):32. doi:10.1186/s40359-015-0089-9. PMID: 26376626; PMCID: PMC4573926.
   PubMedGoogle Scholar
• National Cancer Institute. What is implementation science?; n.d. [accessed 2022 Nov 1]. https://cancercontrol.cancer.gov/is.
   Google Scholar
• National Cancer Institute. Evidence-based cancer control programs; 2020 Oct 2 [accessed 2022 Nov 1]. https://ebccp.cancercontrol.cancer.gov/index.do.
   Google Scholar
• Percy-Laurry A, Adsul P, Uy A, Vinson C Improving evidence-based program repositories: introducing the evidence-based cancer control programs (EBCCP) web repository. Am J Health Promot. 2021 Sep;35(7):897–99. doi:10.1177/08901171211006589. Epub 2021 Apr 8. PMID: 33827272.
   PubMed Web of Science ®Google Scholar
• Vanderpool RC, Cohen E, Crosby RA, Jones MG, Bates W, Casey BR, Collins T “1-2-3 pap” intervention improves HPV vaccine series completion among Appalachian women. J Commun. 2013 Feb;63(1):95–115. doi:10.1111/jcom.12001. Epub 2013 Jan 10. PMID: 26560123; PMCID: PMC4639462.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Zisblatt L, Legler A, Trucks E, Hanchate A, Gorin SS. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine. 2015 Feb 25;33(9):1223–29. doi:10.1016/j.vaccine.2014.11.021. Epub 2014 Nov 24. PMID: 25448095.
   PubMed Web of Science ®Google Scholar
• Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, Hughes CC, Massey J, Keren R, Bell LM, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics. 2013 Jun;131(6):1114–24. doi:10.1542/peds.2012-3122. Epub 2013 May 6. PMID: 23650297; PMCID: PMC3666111.
   PubMed Web of Science ®Google Scholar
• Hopfer S, Clippard JR College women’s HPV vaccine decision narratives. Qual Health Res. 2011 Feb;21(2):262–77. doi:10.1177/1049732310383868. Epub 2010 Sep 14. PMID: 20841433.
   PubMed Web of Science ®Google Scholar
• Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017 Jan;139(1):e20161764. doi:10.1542/peds.2016-1764. Epub 2016 Dec 5. PMID: 27940512; PMCID: PMC5192091.
   PubMed Web of Science ®Google Scholar
• Winer RL, Gonzales AA, Noonan CJ, Buchwald DS A cluster-randomized trial to evaluate a mother-daughter dyadic educational intervention for increasing HPV vaccination coverage in American Indian girls. J Community Health. 2016 Apr;41(2):274–81. doi:10.1007/s10900-015-0093-2. PMID: 26399648; PMCID: PMC4779421.
   PubMed Web of Science ®Google Scholar
• Guide to Community Preventive Services, Community Preventive Services Task Force; n.d. [accessed 2022 Nov 1]. https://www.thecommunityguide.org/.
   Google Scholar
• Bennett C, Edwards D, Sherman SM, Baker P, Waheed DE, Vorsters A, Çevik H S, Karafillakis E, Prue G, Kelly D Which interventions improve HPV vaccination uptake and intention in children, adolescents and young adults? An umbrella review. Sex Transm Infect. 2022 Dec;98(8):599–607. doi:10.1136/sextrans-2022-055504. Epub 2022 Sep 5. PMID: 36396162.
   PubMed Web of Science ®Google Scholar
• Lott BE, Okusanya BO, Anderson EJ, Kram NA, Rodriguez M, Thomson CA, Rosales C, Ehiri JE. Interventions to increase uptake of human papillomavirus (HPV) vaccination in minority populations: a systematic review. Prev Med Rep. 2020 Jul 11;19:101163. doi:10.1016/j.pmedr.2020.101163. PMID: 32714778; PMCID: PMC7372149.
   PubMedGoogle Scholar
• Fisher-Borne M, Preiss AJ, Black M, Roberts K, Saslow D Early outcomes of a multilevel human papillomavirus vaccination pilot intervention in federally qualified health centers. Acad Pediatr. 2018 Mar;18(2S):S79–84. doi:10.1016/j.acap.2017.11.001. PMID: 29502642.
   PubMed Web of Science ®Google Scholar
• Paskett E, Thompson B, Ammerman AS, Ortega AN, Marsteller J, Richardson D. Multilevel interventions to address health disparities show promise in improving population health. Health Aff (Millwood). 2016 Aug 1;35(8):1429–34. doi:10.1377/hlthaff.2015.1360. PMID: 27503968; PMCID: PMC5553289.
   PubMed Web of Science ®Google Scholar
• Calo WA, Gilkey MB, Leeman J, Heisler-MacKinnon J, Averette C, Sanchez S, Kornides ML, Brewer NT. Coaching primary care clinics for HPV vaccination quality improvement: comparing in-person and webinar implementation. Transl Behav Med. 2019 Jan 1;9(1):23–31. doi:10.1093/tbm/iby008. PMID: 29471460; PMCID: PMC6305561.
   PubMed Web of Science ®Google Scholar
• Cassidy B, Braxter B, Charron-Prochownik D, Schlenk EA A quality improvement initiative to increase HPV vaccine rates using an educational and reminder strategy with parents of preteen girls. J Pediatr Health Care. 2014 Mar-Apr;28(2):155–64. doi:10.1016/j.pedhc.2013.01.002. Epub 2013 Mar 20. PMID: 23522561.
   PubMed Web of Science ®Google Scholar
• Grabert BK, Heisler-MacKinnon J, Liu A, Margolis MA, Cox ED, Gilkey MB. Prioritizing and implementing HPV vaccination quality improvement programs in healthcare systems: the perspective of quality improvement leaders. Hum Vaccin Immunother. 2021 Oct 3;17(10):3577–86. doi:10.1080/21645515.2021.1913965. Epub 2021 Jun 21. PMID: 34152924; PMCID: PMC8437543.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Foley S, Hassan A, Jansen E, Preiss S, Isher-Witt J, Fisher-Borne M Impact of a multilevel quality improvement intervention using national partnerships on human papillomavirus vaccination rates. Acad Pediatr. 2021 Sep-Oct;21(7):1134–41. doi:10.1016/j.acap.2021.05.018. Epub 2021 May 20. PMID: 34023489.
   PubMed Web of Science ®Google Scholar
• Fu L, Smith A, Ciotoli C, Dannenbaum M, Jacobs M. An immunization quality improvement learning collaborative in the college health setting. J Am Coll Health. 2021 Oct;20:1–10. doi:10.1080/07448481.2021.1979560. Epub ahead of print. PMID: 34670105.
   Google Scholar
• Oliver K, Beskin K, Noonan L, Shah A, Perkins R, Humiston S. A quality improvement learning collaborative for human papillomavirus vaccination. Pediatr Qual Saf. 2020 Dec 28;6(1):e377. doi:10.1097/pq9.0000000000000377. PMID: 33409429; PMCID: PMC7781351.
   PubMedGoogle Scholar
• Rand CM, Schaffer SJ, Dhepyasuwan N, Blumkin A, Albertin C, Serwint JR, Darden PM, Humiston SG, Mann KJ, Stratbucker W, et al. Provider communication, prompts, and feedback to improve HPV vaccination rates in resident clinics. Pediatrics. 2018 Apr;141(4):e20170498. doi:10.1542/peds.2017-0498. Epub 2018 Mar 14. PMID: 29540572; PMCID: PMC9473325.
   PubMed Web of Science ®Google Scholar
• Rand CM, Tyrrell H, Wallace-Brodeur R, Goldstein NPN, Darden PM, Humiston SG, Albertin CS, Stratbucker W, Schaffer SJ, Davis W, et al. A learning collaborative model to improve human papillomavirus vaccination rates in primary care. Acad Pediatr. 2018 Mar;18(2S):S46–52. doi:10.1016/j.acap.2018.01.003. PMID: 29502638.
   PubMedGoogle Scholar
• Flood T, Wilson IM, Prue G, McLaughlin M, Hughes CM. Impact of school-based educational interventions in middle adolescent populations (15-17yrs) on human papillomavirus (HPV) vaccination uptake and perceptions/knowledge of HPV and its associated cancers: a systematic review. Prev Med. 2020 Oct;139:106168. doi:10.1016/j.ypmed.2020.106168. Epub 2020 Jun 27. PMID: 32603795.
   PubMed Web of Science ®Google Scholar
• Balas EA, Boren SA. Managing clinical knowledge for health care improvement. Yearb Med Inform. 2000;09(01):65–70. doi: 10.1055/s-0038-1637943. PMID: 27699347.
   Google Scholar
• Grant J, Green L, Mason B. Basic research and health: a reassessment of the scientific basis for the support of biomedical science. Res Eval. 2003;12(3):217–24. doi:10.3152/147154403781776618.
   Web of Science ®Google Scholar
• Morris ZS, Wooding S, Grant J The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011 Dec;104(12):510–20. doi:10.1258/jrsm.2011.110180. PMID: 22179294; PMCID: PMC3241518.
   PubMed Web of Science ®Google Scholar
• Berwick DM. Disseminating innovations in health care. JAMA. 2003 Apr 16;289(15):1969–75. doi:10.1001/jama.289.15.1969. PMID: 12697800.
   PubMed Web of Science ®Google Scholar
• Khan S, Chambers D, Neta G Revisiting time to translation: implementation of evidence-based practices (EBPs) in cancer control. Cancer Causes Control. 2021 Mar;32(3):221–30. doi:10.1007/s10552-020-01376-z. Epub 2021 Jan 4. PMID: 33392908.
   PubMed Web of Science ®Google Scholar
• Freeman HP. Commentary on the meaning of race in science and society. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):232s–6s. PMID: 12646516.
   PubMed Web of Science ®Google Scholar
• Stirman SW, Gamarra J, Bartlett B, Calloway A, Gutner C. Empirical examinations of modifications and adaptations to evidence-based psychotherapies: methodologies, impact, and future directions. Clin Psychol (New York). 2017;24(4):396–420. doi:10.1111/cpsp.12218.
   PubMed Web of Science ®Google Scholar
• Escoffery C, Lebow-Skelley E, Udelson H, Boing EA, Wood R, Fernandez ME, Mullen PD. A scoping study of frameworks for adapting public health evidence-based interventions. Transl Behav Med. 2019 Jan 1;9(1):1–10. doi:10.1093/tbm/ibx067. PMID: 29346635; PMCID: PMC6305563.
   PubMed Web of Science ®Google Scholar
• Chambers DA, Norton WE The adaptome: advancing the science of intervention adaptation. Am J Prev Med. 2016 Oct;51(4 Suppl 2):S124–31. doi:10.1016/j.amepre.2016.05.011. Epub 2016 Jun 28. PMID: 27371105; PMCID: PMC5030159.
   PubMed Web of Science ®Google Scholar
• Stirman SW, Miller CJ, Toder K, Calloway A. Development of a framework and coding system for modifications and adaptations of evidence-based interventions. Implement Sci. 2013 Jun 10;8(1):65. doi:10.1186/1748-5908-8-65. PMID: 23758995; PMCID: PMC3686699.
   PubMed Web of Science ®Google Scholar
• Kirk MA, Moore JE, Wiltsey Stirman S, Birken SA. Towards a comprehensive model for understanding adaptations’ impact: the model for adaptation design and impact (MADI). Implement Sci. 2020 Jul 20;15(1):56. doi:10.1186/s13012-020-01021-y. PMID: 32690104; PMCID: PMC7370455.
   PubMed Web of Science ®Google Scholar
• Wiltsey Stirman S, Baumann AA, Miller CJ. The FRAME: an expanded framework for reporting adaptations and modifications to evidence-based interventions. Implement Sci. 2019 Jun 6;14(1):58. doi:10.1186/s13012-019-0898-y. PMID: 31171014; PMCID: PMC6554895.
   PubMedGoogle Scholar
• Miller CJ, Barnett ML, Baumann AA, Gutner CA, Wiltsey-Stirman S. The FRAME-IS: a framework for documenting modifications to implementation strategies in healthcare. Implement Sci. 2021 Apr 7;16(1):36. doi:10.1186/s13012-021-01105-3. PMID: 33827716; PMCID: PMC8024675.
   PubMed Web of Science ®Google Scholar
• Bartholomew LK, Parcel GS, Kok G Intervention mapping: a process for developing theory- and evidence-based health education programs. Health Educ Behav. 1998 Oct;25(5):545–63. doi:10.1177/109019819802500502. PMID: 9768376.
   PubMed Web of Science ®Google Scholar
• Highfield L, Hartman MA, Mullen PD, Rodriguez SA, Fernandez ME, Bartholomew LK. Intervention mapping to adapt evidence-based interventions for use in practice: increasing mammography among African American women. Biomed Res Int. 2015;2015:160103. doi:10.1155/2015/160103. Epub 2015 Oct 26. PMID: 26587531; PMCID: PMC4637430.
   PubMed Web of Science ®Google Scholar
• Walker TJ, Foster M, Szeszulski J, Craig DW, Mullen PD, Fernández ME. Evidence-based intervention (EBI) mapping: a systematic approach to understanding the components and logic of EBIs. BMC Public Health. 2022 Jul 7;22(1):1300. doi:10.1186/s12889-022-13692-x. PMID: 35794615; PMCID: PMC9261043.
   PubMed Web of Science ®Google Scholar
• Evans RE, Craig P, Hoddinott P, Littlecott H, Moore L, Murphy S, O’cathain A, Pfadenhauer L, Rehfuess E, Segrott J, et al. When and how do ‘effective’ interventions need to be adapted and/or re-evaluated in new contexts? The need for guidance. J Epidemiol Community Health. 2019 Jun;73(6):481–82. doi:10.1136/jech-2018-210840. Epub 2019 Feb 20. PMID: 30787038; PMCID: PMC6581090.
   PubMed Web of Science ®Google Scholar
• Moore G, Campbell M, Copeland L, Craig P, Movsisyan A, Hoddinott P, Littlecott H, O’cathain A, Pfadenhauer L, Rehfuess E, et al. Adapting interventions to new contexts-the ADAPT guidance. BMJ. 2021 Aug 3;374:n1679. doi: 10.1136/bmj.n1679. PMID: 34344699; PMCID: PMC8329746.
   Google Scholar
• Miller CJ, Wiltsey-Stirman S, Baumann AA Iterative Decision-making for Evaluation of Adaptations (IDEA): a decision tree for balancing adaptation, fidelity, and intervention impact. J Community Psychol. 2020 May;48(4):1163–77. doi:10.1002/jcop.22279. Epub 2020 Jan 23. PMID: 31970812; PMCID: PMC7261620.
   PubMed Web of Science ®Google Scholar
• Colon-Lopez V, Soto-Abreu R, Medina-Laabes DT, Diaz-Miranda OL, Ortiz AP, Suarez EL, Hull PC. Implementation of the human papillomavirus school-entry requirement in Puerto Rico: barriers and facilitators using the consolidated framework for implementation research. Hum Vaccin Immunother. 2021 Nov 2;17(11):4423–32. doi:10.1080/21645515.2021.1955609. Epub 2021 Aug 9. PMID: 34369857; PMCID: PMC8828084.
   PubMed Web of Science ®Google Scholar
• Hopfer S, Duong HT, Garcia S, Tanjasiri SP Health information source characteristics matter: adapting the dissemination of an HPV vaccine intervention to reach latina and Vietnamese women. J Prim Prev. 2021 Oct;42(5):511–29. doi:10.1007/s10935-021-00643-2. Epub 2021 Jul 20. PMID: 34283351; PMCID: PMC8290389.
   PubMed Web of Science ®Google Scholar
• Hopfer S, Phillips KK, Weinzierl M, Vasquez HE, Alkhatib S, Harabagiu SM. Adaptation and dissemination of a national cancer institute HPV vaccine evidence-based cancer control program to the social media messaging environment. Front Digit Health. 2022 Jul 27;4:819228. doi:10.3389/fdgth.2022.819228. PMID: 35966142; PMCID: PMC9363572.
   PubMedGoogle Scholar
• Rodriguez SA, Roncancio AM, Savas LS, Lopez DM, Vernon SW, Fernandez ME. Using intervention mapping to develop and adapt two educational interventions for parents to increase HPV vaccination among Hispanic adolescents. Front Public Health. 2018 Jun 15;6:164. doi:10.3389/fpubh.2018.00164. PMID: 29963542; PMCID: PMC6013574.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang L. Cultural adaptation in HPV vaccine intervention among racial and ethical minority population: a systematic literature review. Health Educ Res. 2022 Jan 27;36(5):479–93. doi:10.1093/her/cyab034. PMID: 34542147.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Parks MJ, Margolis MA, McRee AL, Terk JV Implementing evidence-based strategies to improve HPV vaccine delivery. Pediatrics. 2019 Jul;144(1):e20182500. doi:10.1542/peds.2018-2500. Epub 2019 Jun 17. PMID: 31209158; PMCID: PMC6615521.
   PubMed Web of Science ®Google Scholar
• Adsul P, Chambers D, Brandt HM, Fernandez ME, Ramanadhan S, Torres E, Leeman J, Baquero B, Fleischer L, Escoffery C, et al. Grounding implementation science in health equity for cancer prevention and control. Implement Sci Commun. 2022 Jun 3;3(1):56. doi:10.1186/s43058-022-00311-4. PMID: 35659151; PMCID: PMC9164317.
   PubMedGoogle Scholar
• Aschbrenner KA, Mueller NM, Banerjee S, Bartels SJ. Applying an equity lens to characterizing the process and reasons for an adaptation to an evidenced-based practice. Implement Res Pract. 2021 Jan-Dec;2. doi: 10.1177/26334895211017252. Epub 2021 May 26. PMID: 34514417; PMCID: PMC8428660.
   PubMedGoogle Scholar
• Ramanadhan S, Davis MM, Armstrong R, Baquero B, Ko LK, Leng JC, Salloum RG, Vaughn NA, Brownson RC. Participatory implementation science to increase the impact of evidence-based cancer prevention and control. Cancer Causes Control. 2018 Mar;29(3):363–69. doi:10.1007/s10552-018-1008-1. Epub 2018 Feb 7. PMID: 29417296; PMCID: PMC5858707.
   PubMed Web of Science ®Google Scholar
• Nápoles AM, Santoyo-Olsson J, Stewart AL. Methods for translating evidence-based behavioral interventions for health-disparity communities. Prev Chronic Dis. 2013 Nov 21;10:E193. doi:10.5888/pcd10.130133. PMID: 24262025; PMCID: PMC3839588.
   PubMed Web of Science ®Google Scholar
• Nápoles AM, Stewart AL. Transcreation: an implementation science framework for community-engaged behavioral interventions to reduce health disparities. BMC Health Serv Res. 2018 Sep 12;18(1):710. doi:10.1186/s12913-018-3521-z. PMID: 30208873; PMCID: PMC6134771.
   PubMedGoogle Scholar
• Salloum RG, Wagner TH, Midboe AM, Daniels SI, Quanbeck A, Chambers DA. The economics of adaptations to evidence-based practices. Implement Sci Commun. 2022 Sep 24;3(1):100. doi:10.1186/s43058-022-00345-8. PMID: 36153575; PMCID: PMC9509646.
   PubMedGoogle Scholar
• Proctor E, Ramsey AT, Saldana L, Maddox TM, Chambers DA, Rc B. FAST: a framework to assess speed of translation of health innovations to practice and policy. Glob Implement Res Appl. 2022;2(2):107–19. doi:10.1007/s43477-022-00045-4. Epub 2022 Jun 2. PMID: 35669171; PMCID: PMC9161655.
   PubMedGoogle Scholar
• Ramsey AT, Proctor EK, Chambers DA, Garbutt JM, Malone S, Powderly WG, Bierut LJ Designing for accelerated translation (DART) of emerging innovations in health. J Clin Transl Sci. 2019 Jun;3(2–3):53–58. doi:10.1017/cts.2019.386. Epub 2019 Jul 30. PMID: 31528365; PMCID: PMC6746422.
   PubMedGoogle Scholar
• Brownson RC, Jacobs JA, Tabak RG, Hoehner CM, Stamatakis KA Designing for dissemination among public health researchers: findings from a national survey in the United States. Am J Public Health. 2013 Sep;103(9):1693–99. doi:10.2105/AJPH.2012.301165. Epub 2013 Jul 18. PMID: 23865659; PMCID: PMC3966680.
   PubMed Web of Science ®Google Scholar
• Kwan BM, Brownson RC, Glasgow RE, Morrato EH, Luke DA. Designing for dissemination and sustainability to promote equitable impacts on health. Annu Rev Public Health. 2022 Apr 5;43(1):331–53. doi:10.1146/annurev-publhealth-052220-112457. Epub 2022 Jan 4. PMID: 34982585; PMCID: PMC9260852.
   PubMedGoogle Scholar
• Shelton RC, Chambers DA, Glasgow RE. An extension of RE-AIM to enhance sustainability: addressing dynamic context and promoting health equity over time. Front Public Health. 2020 May 12;8:134. doi:10.3389/fpubh.2020.00134. PMID: 32478025; PMCID: PMC7235159.
   PubMed Web of Science ®Google Scholar
• Eisman AB, Kim B, Salloum RG, Shuman CJ, Glasgow RE. Advancing rapid adaptation for urgent public health crises: using implementation science to facilitate effective and efficient responses. Front Public Health. 2022 Aug 24;10:959567. doi:10.3389/fpubh.2022.959567. PMID: 36091566; PMCID: PMC9448975.
   PubMed Web of Science ®Google Scholar